Risk ManagementParadigm Health Goes Live With Amgen and AstraZeneca Trials Simultaneously, Exposing Partners to Catastrophic Data RiskSalvado•May 1, 2026
Corporate StrategyAmgen Merges R&D and AI Under Single Leader as Generative Oncology Race Heats UpSalvado•Apr 30, 2026
Enterprise Technology InvestmentAmgen Leads Fortune 500 AI Restructuring as Enterprise Infrastructure Moves Past Pilot PhaseSalvado•Apr 30, 2026
